KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Assets (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Assets for 13 consecutive years, with 0.03% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.03% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03%, a 0.0% change, with the full-year FY2025 number at 0.03%, changed 0.0% from a year prior.
  • Return on Assets was 0.03% for Q4 2025 at AbbVie, up from 0.02% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q3 2022 to a low of 0.02% in Q3 2025.
  • A 5-year average of 0.05% and a median of 0.04% in 2021 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 5bps in 2021; the steepest drop was -6bps in 2021.
  • AbbVie's Return on Assets stood at 0.08% in 2021, then grew by 8bps to 0.08% in 2022, then tumbled by -57bps to 0.04% in 2023, then dropped by -14bps to 0.03% in 2024, then grew by 3bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Return on Assets are 0.03% (Q4 2025), 0.02% (Q3 2025), and 0.03% (Q2 2025).